Evidence map›Paper›PMID 30891627›Full record

ReviewSeminars in immunopathology2019

The pathogenicity of Th17 cells in autoimmune diseases.

Keiko Yasuda, Yusuke Takeuchi, Keiji Hirota

Erratum issued Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Seminars in immunopathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05163743 (COVID-19 Vaccination in Subjects With Obesity), which is not on this map. Cited by 309 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
309citing papers in PubMed, 2 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05163743 naunknown statusnot on this mapstarted 2021, after this paper: background citation

COVID-19 Vaccination in Subjects With Obesity: Impact of Metabolic Health and the Role of a Ketogenic Diet

TypeinterventionalSponsorUniversity of Roma La SapienzaRan2021 to 2021Enrolled24ConditionsObesityArmsLow Calorie Ketogenic Diet
3 · Its place in the literature

Who cites it

309 citing papers in PubMed, 2 syntheses or guidelines pooled it, 563 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Alterations in CD4Endocrine, metabolic & immune disorders drug targets · 2024
    Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

249 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Keiko YasudaLaboratory of Integrative Biological Science, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, 606-8507, Japan.
Yusuke TakeuchiLaboratory of Integrative Biological Science, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, 606-8507, Japan.
Keiji HirotaLaboratory of Integrative Biological Science, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, 606-8507, Japan. hkeiji@infront.kyoto-u.ac.jp.
Kyoto University · JPOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IL-17-producing T helper (Th17) cells have been implicated in the pathogenesis of many inflammatory and autoimmune diseases. Targeting the effector cytokines IL-17 and GM-CSF secreted by autoimmune Th17 cells has been shown to be effective for the treatment of the diseases. Understanding a molecular basis of Th17 differentiation and effector functions is therefore critical for the regulation of the pathogenicity of tissue Th17 cells in chronic inflammation. Here, we discuss the roles of proinflammatory cytokines and environmental stimuli in the control of Th17 differentiation and chronic tissue inflammation by pathogenic Th17 cells in humans and in mouse models of autoimmune diseases. We also highlight recent advances in the regulation of pathogenic Th17 cells by gut microbiota and immunometabolism in autoimmune arthritis.

Indexed as

AutoimmunityDisease SusceptibilityAnimalsAutoimmune DiseasesCell DifferentiationCytokinesEnvironmental ExposureGastrointestinal MicrobiomeGene Expression RegulationHumansInflammation MediatorsInterleukin-17Lymphocyte ActivationPhenotypeSignal TransductionTh17 CellsCytokinesIL17A protein, humanInflammation MediatorsInterleukin-17Autoimmune arthritisEAEGM-CSFIL-17Rheumatoid arthritisTh17 cells

Identifiers

PMID30891627
OpenAlexW2939532730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.